| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 10/01/2009 | WO2009077484A3 A cyano piperidinyl-phenil-oxazolidinone and use thereof. |
| 10/01/2009 | WO2009074300A3 Hedgehog pathway antagonists and therapeutic applications thereof |
| 10/01/2009 | US20090247591 Substituted cyclohexyldiamines |
| 10/01/2009 | US20090247545 Substituted oxazolidinone derivatives |
| 10/01/2009 | US20090247534 New compounds |
| 10/01/2009 | US20090247527 Substituted gamma lactams as therapeutic agents |
| 10/01/2009 | US20090247526 Glucokinase activators |
| 10/01/2009 | US20090247525 Sigma receptor inhibitors |
| 10/01/2009 | US20090247524 HSP90 Inhibitor |
| 10/01/2009 | US20090247523 Carboxamide 4-[(4-pyridyl)amino]pyrimidines useful as hcv inhibitors |
| 10/01/2009 | US20090247520 INHIBITORS OF ANTIGEN RECEPTOR-INDUCED NF-kappa B ACTIVATION |
| 10/01/2009 | US20090247519 Amino-ethyl-amino-aryl (aeaa) compounds and their use |
| 10/01/2009 | US20090247517 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 10/01/2009 | US20090247513 Benzothiophene compounds having antiinfective activity |
| 10/01/2009 | US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders |
| 10/01/2009 | US20090247504 Indazole Derivatives for Treatment of Alzheimer's Disease |
| 10/01/2009 | US20090247503 5-demethoxyfumagillol and derivatives thereof |
| 10/01/2009 | US20090247499 Sulfonylated piperazines as cannabinoid-1 receptor modulators |
| 10/01/2009 | US20090247474 3-Aminopyrrolidine Derivatives As Modulators Of Chemokine Receptors |
| 10/01/2009 | US20090246169 Indolopyridines as eg5 kinesin modulators |
| 10/01/2009 | US20090246137 Pyridyl derivatives as cftr modulators |
| 10/01/2009 | CA2719743A1 Substituted cyclohexyldiamines |
| 10/01/2009 | CA2719477A1 Hydroxamate-based inhibitors of deacetylases b |
| 10/01/2009 | CA2718727A1 Heterocyclic compound |
| 09/30/2009 | EP2105441A1 Alanyl aminopeptidase and dipeptidylpeptidase IV dual inhibitors for the treatment of immunological, inflammatory, neuronal and other illnesses |
| 09/30/2009 | EP2105436A1 Lactam-containing compounds and derivatives thereof as factor XA inhibitors |
| 09/30/2009 | EP2104670A2 Novel triazinedione derivatives as gaba-b receptor modulators |
| 09/30/2009 | EP2104669A2 Inhibitors of akt activity |
| 09/30/2009 | EP2104664A1 Tetrahydrobenzoisoxazole - and tetrahydroindazole derivatives as modulators of the mitotic motor protein |
| 09/30/2009 | EP1692117B1 Oxazole derivatives of tetracyclines |
| 09/30/2009 | EP1581523B1 Pyrazole-derivatives as factor xa inhibitors |
| 09/30/2009 | EP1553089B1 Antagonist of melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient |
| 09/30/2009 | EP1501361B1 3-heteroaryl substituted 5-methyloxymethyl isoxazolines used as herbicides |
| 09/30/2009 | EP1435944B1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 09/30/2009 | CN101547921A Aminoacyl prodrug derivatives and medicaments for treatment of thromboembolic disorders |
| 09/30/2009 | CN101547920A Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound |
| 09/30/2009 | CN101544592A N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
| 09/30/2009 | CN100545151C Oxazole derivatives of tetracyclines |
| 09/30/2009 | CN100545150C Pyridine ring containing oxazolidinone compounds and preparation process and application thereof |
| 09/29/2009 | US7595343 Inhibitors of histone deacetylase |
| 09/29/2009 | US7595334 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors |
| 09/29/2009 | US7595329 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; gastroesophageal reflux disease, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability |
| 09/29/2009 | US7595321 Useful for the prevention and/or treatment of cognitive disorders; 3-Amino-N-(2-cyanoethyl)-6-[4-(pyrrolidin-1-ylsulfonyl)phenyl]pyrazine-2-carboxamide, for example |
| 09/29/2009 | US7595319 Compounds having selective inhibiting effect at GSK3 |
| 09/29/2009 | US7595314 Such as (2-morpholin-4-yl-5-nitro-phenyl)-[4-(5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-methanone; for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease |
| 09/29/2009 | CA2550372C Alpha-hydroxy amides as bradykinin antagonists or inverse agonists |
| 09/29/2009 | CA2494601C N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes |
| 09/29/2009 | CA2371853C Heterocyclic benzenesulphonamide compounds as bradykinin antagonists |
| 09/24/2009 | WO2009117676A2 Novel piperidine derivatives as inhibitors of stearoyl-coa desaturase |
| 09/24/2009 | WO2009117378A2 Therapeutic amides |
| 09/24/2009 | WO2009117109A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| 09/24/2009 | WO2009116882A1 Crystal forms of 5- [3- (2, 5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl) [1,2,3] oxadiazol-5-yl] -3-nit robenzene-1, 2-diol |
| 09/24/2009 | WO2009116729A2 Method for refining of high purity of tacrolimus |
| 09/24/2009 | WO2009116081A2 An improved process for the preparation of aprepitant |
| 09/24/2009 | WO2009115874A2 Novel heterocyclic compounds, pharmaceutical compositions containing them and processes for their preparation |
| 09/24/2009 | WO2009114993A1 Pyridazinones, the preparation and the use thereof |
| 09/24/2009 | WO2009087212A3 Pyridine derivatives |
| 09/24/2009 | WO2009068682A3 Phenyl-oxetanyl-derivatives |
| 09/24/2009 | WO2009067960A3 A method of manufacturing (3r,4s)-l-(4-fluorophenyl)-3-[(3s)-3-(4-fluorophenyl)-3- hydroxypropyl)]-4-(4-hydroxyphenyl)-2-azetidinone and its intermediates |
| 09/24/2009 | WO2009063028A3 Substituted amides, manufacturing and use thereof as medicaments |
| 09/24/2009 | WO2009032668A3 2 -biphenylamino-4 -aminopyrimidine derivatives as kinase inhibitors |
| 09/24/2009 | WO2008018090A3 An improved process for the preparation of zolmitriptan |
| 09/24/2009 | US20090240062 Compound derived from cyclopentadienone, preparation method thereof and el element using the same |
| 09/24/2009 | US20090240052 Novel anthranilic acid derivative or salt thereof |
| 09/24/2009 | US20090239982 Ultraviolet Absorbent and Heterocyclic Compound |
| 09/24/2009 | US20090239915 Substituted 2-phenyl-benzimidazoles and their use as pharmaceuticals |
| 09/24/2009 | US20090239909 Treatment of metabolic syndrome with lactams |
| 09/24/2009 | US20090239903 Tetrahydroquinoline analogues as muscarinic agonists |
| 09/24/2009 | US20090239889 Spiro[2-cyclohexene-1,3'-[3H]indole]-2',4(1'H)-diones and 4-hydroxyspiro[2-cyclohexene-1,3'-[3H]indol]-2'(1'H)-ones; act as antagonists of mdm2 interactions; useful as potent and selective anticancer agents |
| 09/24/2009 | US20090239867 1-(2,4-Dimethoxybenzyl)-5-oxo-pyrrolidine-3-carboxylic Acid Methyl Ester; for treating inflammatory bowel disease, glaucoma or ocular hypertension, asthma or baldness; prostaglandin EP2 agonists |
| 09/24/2009 | US20090239866 Peptide deformylase inhibitors |
| 09/24/2009 | US20090239865 Dibenzyl amine compounds and derivatives |
| 09/24/2009 | US20090239864 6- (pyridinyl) -4-pyrimidone derivates as tau protein kinase 1 inhibitors |
| 09/24/2009 | US20090239863 1-aryl-or 1- alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 09/24/2009 | US20090239862 Substituted Imidazole 4-Carboxamides as Cholecystokinin-1 Receptor Modulators |
| 09/24/2009 | US20090239861 Quinazoline derivatives as anticancer agents |
| 09/24/2009 | US20090239860 Novel benzofuran derivative, medicinal composition containing the same, and uses of these |
| 09/24/2009 | US20090239859 Protein kinase modulators |
| 09/24/2009 | US20090239858 Therapeutic amides |
| 09/24/2009 | US20090239857 Triamine derivative |
| 09/24/2009 | US20090239848 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE |
| 09/24/2009 | US20090239847 Organic compounds |
| 09/24/2009 | US20090239846 Novel Compounds |
| 09/24/2009 | US20090239845 Pyrazole compounds as prostaglandin receptors ligands |
| 09/24/2009 | US20090239843 Bridged diazepan orexin receptor antagonists |
| 09/24/2009 | US20090239810 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE |
| 09/24/2009 | US20090239798 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide |
| 09/24/2009 | CA2718936A1 Novel heterocyclic compounds and uses therof |
| 09/24/2009 | CA2718772A1 Crystal forms of 5-[3-(2,5-dichloro-4,6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4]oxadiazol-5-yl]-3-nit robenzene-1,2-diol |
| 09/24/2009 | CA2718693A1 Substituted pyrazolamides and the use thereof |
| 09/24/2009 | CA2718264A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| 09/23/2009 | EP2102198A1 Sulfonyl-phenyl-2h-[1,2,4]oxodiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals |
| 09/23/2009 | EP2102197A1 5-([1,3,4]oxadiazol-2-yl)-1h-indazol and 5-([1,3,4]thiadiazol-2-yl)-1h-indazol derivatives as sgk inhibitors for the treatment of diabetes |
| 09/23/2009 | EP2102190A1 Compounds and compositions as kinase inhibitors |
| 09/23/2009 | EP2102186A1 Indoles |
| 09/23/2009 | EP2102181A1 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides |
| 09/23/2009 | EP2102169A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 09/23/2009 | EP2102162A1 Phenylic derivatives and use thereof as drugs |
| 09/23/2009 | EP0946508B1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| 09/23/2009 | CN101538268A Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |